Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Randomized, Double Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of SAB01 in Healthy Participants

NCT07815561 is registered in ClinicalTrials.gov with Santa Ana Bio as lead sponsor.

NCT NCT07815561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07815561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Randomized, Double Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of SAB01 in Healthy Participants
Lead sponsor
Santa Ana Bio
Phase
Phase 1
Overall status
Recruiting
Start date
August 31, 2026
Completion date
May 31, 2027
Enrollment
88 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult participants